Results 71 to 80 of about 3,222,323 (307)

The strategic importance of mRNA vaccine technologies in Africa for achieving public health independence

open access: yesCommunications Medicine
To build mRNA vaccine manufacturing capacity in Africa, significant progress has been made with human, technical and regulatory capacity development.
Patrick B. Arbuthnot   +6 more
doaj   +1 more source

Pharmacokinetic interaction between raltegravir and rifampicin in an infant with HIV exposed to active TB: a case report

open access: yesAntiviral Therapy, 2022
We report a case of an infant with HIV receiving raltegravir granules for oral suspension and rifampicin-based TB prophylaxis. Raltegravir trough levels remained subtherapeutic and viral load increased during concurrent rifampicin therapy despite using ...
Marlotte AA van der Veer   +6 more
doaj   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini   +9 more
wiley   +1 more source

Risk of hospitalization for infection syndrome and infection-related mortality comparing HCV patients who received antiviral therapy with those who did not receive antiviral therapy.

open access: yes, 2019
Risk of hospitalization for infection syndrome and infection-related mortality comparing HCV patients who received antiviral therapy with those who did not receive antiviral therapy.
Yaa-Hui Dong (3255495)   +5 more
core   +1 more source

Incidence, Risk Factors, and Management of Adverse Events in Contemporary, Real‐World Care of Children With Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, EarlyView.
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAEs and SAEs) in children with newly diagnosed juvenile idiopathic arthritis (JIA) in Canada. Methods We enrolled patients within three months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI ...
Bashayer Alnuaimi   +88 more
wiley   +1 more source

Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C

open access: yes, 2009
BACKGROUND/AIMS: The prevalence and clinical implications of non- alcoholic fatty liver disease in patients with chronic hepatitis C remain unknown in Taiwan.
LIU, CHUN-JEN;JENG, YUNG-MING;CHEN, PEI-JER;LAI, MING-YANG;KAO, JIA-HORNG;CHEN, DING-SHINN   +1 more
core  

Innate Immunocompetent hiPSC‐Derived Neurospheroids Capture Early CNS Responses to rAAV

open access: yesAdvanced Science, EarlyView.
Knowledge of human CNS immune responses to AAV‐based gene therapies remains limited due to the lack of immune‐competent human models. Here, a hiPSC‐derived 3D neuroimmune platform integrating neurospheroids and microglia is established using stirred‐tank bioreactors.
Catarina M. Gomes   +14 more
wiley   +1 more source

The patients’ baseline characteristics before antiviral therapy (n = 196).

open access: yes, 2018
The patients’ baseline characteristics before antiviral therapy (n = 196).
Michitaka Honda (4672696)   +6 more
core   +1 more source

Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B [PDF]

open access: yes, 2010
BACKGROUND: Large clinical studies assessing long-term adefovir dipivoxil salvage monotherapy in patients with lamivudine-resistant chronic hepatitis B (CHB) are lacking, particularly in patients positive for hepatitis B e antigen (HBeAg).
안상훈   +5 more
core   +1 more source

Engineering Microbial Particles for Next‐Generation Biomedical Platforms

open access: yesAdvanced Science, EarlyView.
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy